118 related articles for article (PubMed ID: 30617134)
1. Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular Subtypes.
Binzer-Panchal A; Hardell E; Viklund B; Ghaderi M; Bosse T; Nucci MR; Lee CH; Hollfelder N; Corcoran P; Gonzalez-Molina J; Moyano-Galceran L; Bell DA; Schoolmeester JK; Måsbäck A; Kristensen GB; Davidson B; Lehti K; Isaksson A; Carlson JW
Clin Cancer Res; 2019 Apr; 25(7):2155-2165. PubMed ID: 30617134
[TBL] [Abstract][Full Text] [Related]
2. A prognosis based classification of undifferentiated uterine sarcomas: identification of mitotic index, hormone receptors and YWHAE-FAM22 translocation status as predictors of survival.
Gremel G; Liew M; Hamzei F; Hardell E; Selling J; Ghaderi M; Stemme S; Pontén F; Carlson JW
Int J Cancer; 2015 Apr; 136(7):1608-18. PubMed ID: 25130488
[TBL] [Abstract][Full Text] [Related]
3. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
[TBL] [Abstract][Full Text] [Related]
4. Uterine Sarcoma, Version 1.2016: Featured Updates to the NCCN Guidelines.
Koh WJ; Greer BE; Abu-Rustum NR; Apte SM; Campos SM; Cho KR; Chu C; Cohn D; Crispens MA; Dizon DS; Dorigo O; Eifel PJ; Fisher CM; Frederick P; Gaffney DK; George S; Han E; Higgins S; Huh WK; Lurain JR; Mariani A; Mutch D; Fader AN; Remmenga SW; Reynolds RK; Tillmanns T; Valea FA; Yashar CM; McMillian NR; Scavone JL;
J Natl Compr Canc Netw; 2015 Nov; 13(11):1321-31. PubMed ID: 26553763
[TBL] [Abstract][Full Text] [Related]
5. Progesterone Receptor Expression Is an Independent Prognosticator in FIGO Stage I Uterine Leiomyosarcoma.
Davidson B; Kjæreng ML; Førsund M; Danielsen HE; Kristensen GB; Abeler VM
Am J Clin Pathol; 2016 Apr; 145(4):449-58. PubMed ID: 27149024
[TBL] [Abstract][Full Text] [Related]
6. Machine learning analysis of gene expression data reveals novel diagnostic and prognostic biomarkers and identifies therapeutic targets for soft tissue sarcomas.
van IJzendoorn DGP; Szuhai K; Briaire-de Bruijn IH; Kostine M; Kuijjer ML; Bovée JVMG
PLoS Comput Biol; 2019 Feb; 15(2):e1006826. PubMed ID: 30785874
[TBL] [Abstract][Full Text] [Related]
7. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
D'Angelo E; Spagnoli LG; Prat J
Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
[TBL] [Abstract][Full Text] [Related]
8. High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies.
Toulmonde M; Lucchesi C; Verbeke S; Crombe A; Adam J; Geneste D; Chaire V; Laroche-Clary A; Perret R; Bertucci F; Bertolo F; Bianchini L; Dadone-Montaudie B; Hembrough T; Sweet S; Kim YJ; Cecchi F; Le Loarer F; Italiano A
EBioMedicine; 2020 Dec; 62():103131. PubMed ID: 33254023
[TBL] [Abstract][Full Text] [Related]
9. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
[TBL] [Abstract][Full Text] [Related]
10. Validation of a Mitotic Index Cutoff as a Prognostic Marker in Undifferentiated Uterine Sarcomas.
Hardell E; Josefson S; Ghaderi M; Skeie-Jensen T; Westbom-Fremer S; Cheek EH; Bell D; Selling J; Schoolmeester JK; Måsbäck A; Davidson B; Carlson JW
Am J Surg Pathol; 2017 Sep; 41(9):1231-1237. PubMed ID: 28622181
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors associated with uterine sarcomas: the experience of a single institution.
Barquet-Muñoz SA; Isla-Ortiz D; Montalvo-Esquivel G; Cantú-de-León D; Salcedo-Hernández RA; Cordoba-Gonzalez V; Herrera-Gómez Á
J Obstet Gynaecol; 2019 Feb; 39(2):231-236. PubMed ID: 30354797
[TBL] [Abstract][Full Text] [Related]
12. Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis.
Xiong J; Xiong K; Bing Z
Cancer Biomark; 2018 Feb; 21(3):535-546. PubMed ID: 29226853
[TBL] [Abstract][Full Text] [Related]
13. Macrophage infiltration and genetic landscape of undifferentiated uterine sarcomas.
Przybyl J; Kowalewska M; Quattrone A; Dewaele B; Vanspauwen V; Varma S; Vennam S; Newman AM; Swierniak M; Bakuła-Zalewska E; Siedlecki JA; Bidzinski M; Cools J; van de Rijn M; Debiec-Rychter M
JCI Insight; 2017 Jun; 2(11):. PubMed ID: 28570276
[TBL] [Abstract][Full Text] [Related]
14. A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas.
Wolfson AH; Wolfson DJ; Sittler SY; Breton L; Markoe AM; Schwade JG; Houdek PV; Averette HE; Sevin BU; Penalver M
Gynecol Oncol; 1994 Jan; 52(1):56-62. PubMed ID: 8307502
[TBL] [Abstract][Full Text] [Related]
15. GIST Manifesting as a Retroperitoneal Tumor: Clinicopathologic Immunohistochemical, and Molecular Genetic Study of 112 Cases.
Miettinen M; Felisiak-Golabek A; Wang Z; Inaguma S; Lasota J
Am J Surg Pathol; 2017 May; 41(5):577-585. PubMed ID: 28288036
[TBL] [Abstract][Full Text] [Related]
16. High-grade Müllerian Adenosarcoma: Genomic and Clinicopathologic Characterization of a Distinct Neoplasm With Prevalent TP53 Pathway Alterations and Aggressive Behavior.
Hodgson A; Amemiya Y; Seth A; Djordjevic B; Parra-Herran C
Am J Surg Pathol; 2017 Nov; 41(11):1513-1522. PubMed ID: 28834809
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and surgical therapy of uterine sarcoma.
Vrzic-Petronijevic S; Likic-Ladjevic I; Petronijevic M; Argirovic R; Ladjevic N
Acta Chir Iugosl; 2006; 53(3):67-72. PubMed ID: 17338203
[TBL] [Abstract][Full Text] [Related]
18. Undifferentiated uterine sarcoma: a rare, not well known and aggressive disease: report of 13 cases.
Ríos I; Rovirosa A; Morales J; Gonzalez-Farre B; Arenas M; Ordi J; Pahisa J; Biete A
Arch Gynecol Obstet; 2014 Nov; 290(5):993-7. PubMed ID: 24958349
[TBL] [Abstract][Full Text] [Related]
19. Sarcomas With CIC-rearrangements Are a Distinct Pathologic Entity With Aggressive Outcome: A Clinicopathologic and Molecular Study of 115 Cases.
Antonescu CR; Owosho AA; Zhang L; Chen S; Deniz K; Huryn JM; Kao YC; Huang SC; Singer S; Tap W; Schaefer IM; Fletcher CD
Am J Surg Pathol; 2017 Jul; 41(7):941-949. PubMed ID: 28346326
[TBL] [Abstract][Full Text] [Related]
20. FOXP3+ T cells in uterine sarcomas are associated with favorable prognosis, low extracellular matrix expression and reduced YAP activation.
Gultekin O; Gonzalez-Molina J; Hardell E; Moyano-Galceran L; Mitsios N; Mulder J; Kokaraki G; Isaksson A; Sarhan D; Lehti K; Carlson JW
NPJ Precis Oncol; 2021 Nov; 5(1):97. PubMed ID: 34799669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]